Delayed
OTC Markets
10:59:36 2024-05-07 am EDT
|
5-day change
|
1st Jan Change
|
0.002
USD
|
0.00%
|
|
-60.00%
|
-20.00%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
161.4
|
254.4
|
326
|
1,477
|
1,668
|
556.1
|
Enterprise Value (EV)
1 |
269.9
|
419.4
|
614.8
|
1,729
|
1,629
|
1,473
|
P/E ratio
|
-1.3
x
|
-0.9
x
|
-1.16
x
|
-3.28
x
|
-5.55
x
|
-0.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.13
x
|
4
x
|
2.14
x
|
8.53
x
|
4.88
x
|
2.06
x
|
EV / Revenue
|
1.88
x
|
6.59
x
|
4.03
x
|
9.99
x
|
4.77
x
|
5.46
x
|
EV / EBITDA
|
-9.59
x
|
-3.28
x
|
-5.25
x
|
-15.2
x
|
-10.5
x
|
-2.56
x
|
EV / FCF
|
-7.15
x
|
-5.75
x
|
-7.17
x
|
-11.8
x
|
-22.8
x
|
-3.82
x
|
FCF Yield
|
-14%
|
-17.4%
|
-13.9%
|
-8.46%
|
-4.38%
|
-26.1%
|
Price to Book
|
-0.85
x
|
-1.17
x
|
-1.42
x
|
-8.55
x
|
6.78
x
|
-1.14
x
|
Nbr of stocks (in thousands)
|
43,034
|
76,163
|
105,503
|
239,211
|
308,239
|
363,492
|
Reference price
2 |
3.750
|
3.340
|
3.090
|
6.175
|
5.410
|
1.530
|
Announcement Date
|
4/17/18
|
10/1/19
|
3/13/20
|
3/5/21
|
3/9/22
|
3/16/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
143.4
|
63.6
|
152.6
|
173.1
|
341.8
|
269.8
|
EBITDA
1 |
-28.16
|
-127.8
|
-117.1
|
-114.1
|
-155.7
|
-575.8
|
EBIT
1 |
-39.52
|
-132.7
|
-121.7
|
-123.4
|
-165.4
|
-592.7
|
Operating Margin
|
-27.55%
|
-208.66%
|
-79.76%
|
-71.29%
|
-48.39%
|
-219.63%
|
Earnings before Tax (EBT)
1 |
-72.03
|
-230.2
|
-242.1
|
-326.6
|
-279.9
|
-546.1
|
Net income
1 |
-72.33
|
-230.2
|
-242.8
|
-331
|
-271
|
-528.5
|
Net margin
|
-50.42%
|
-361.98%
|
-159.13%
|
-191.2%
|
-79.27%
|
-195.86%
|
EPS
2 |
-2.895
|
-3.693
|
-2.667
|
-1.880
|
-0.9746
|
-1.694
|
Free Cash Flow
1 |
-37.72
|
-72.96
|
-85.69
|
-146.3
|
-71.31
|
-385.2
|
FCF margin
|
-26.3%
|
-114.71%
|
-56.17%
|
-84.49%
|
-20.86%
|
-142.75%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/17/18
|
10/1/19
|
3/13/20
|
3/5/21
|
3/9/22
|
3/16/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
109
|
165
|
289
|
252
|
-
|
917
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
38.4
|
-
|
Leverage (Debt/EBITDA)
|
-3.855
x
|
-1.291
x
|
-2.466
x
|
-2.21
x
|
-
|
-1.593
x
|
Free Cash Flow
1 |
-37.7
|
-73
|
-85.7
|
-146
|
-71.3
|
-385
|
ROE (net income / shareholders' equity)
|
37.7%
|
106%
|
103%
|
153%
|
-532%
|
547%
|
ROA (Net income/ Total Assets)
|
-17.6%
|
-61.7%
|
-52.6%
|
-40.2%
|
-17.6%
|
-41.6%
|
Assets
1 |
412
|
372.9
|
461.1
|
823.5
|
1,543
|
1,269
|
Book Value Per Share
2 |
-4.400
|
-2.840
|
-2.170
|
-0.7200
|
0.8000
|
-1.340
|
Cash Flow per Share
2 |
1.250
|
0.5900
|
0
|
0.1200
|
1.570
|
0.1800
|
Capex
1 |
4.41
|
12.5
|
13.1
|
12.8
|
45.6
|
106
|
Capex / Sales
|
3.08%
|
19.61%
|
8.57%
|
7.38%
|
13.35%
|
39.26%
|
Announcement Date
|
4/17/18
|
10/1/19
|
3/13/20
|
3/5/21
|
3/9/22
|
3/16/23
|
|
1st Jan change
|
Capi.
|
---|
| -20.00% | 745K | | +17.73% | 66.69B | | +1.61% | 49.2B | | +16.33% | 41.24B | | +18.68% | 25.89B | | +12.78% | 19.81B | | -21.87% | 15.86B | | -10.29% | 15.23B | | +2.32% | 15.35B | | -22.30% | 13.36B |
Other Specialty Chemicals
|